Eesti - eesti - Ravimiamet

brooks laboratories limited - prednisoloon - süstelahus - 25mg 1ml 1ml 10tk

Eesti - eesti - Ravimiamet

infectopharm - tobramütsiin - süste-/infusioonilahus - 40mg 1ml 2ml 10tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - gemtsitabiin - infusioonilahuse kontsentraat - 38mg 1ml 39.5ml 1tk; 38mg 1ml 5.26ml 1tk; 38mg 1ml 52.6ml 1tk; 38mg 1ml 26.3ml 1tk

Eesti - eesti - Ravimiamet

upjohn eesv - amlodipiin - tablett - 5mg 10tk; 5mg 28tk; 5mg 30tk; 5mg 98tk; 5mg 14tk; 5mg 300tk; 5mg 50tk; 5mg 60tk; 5mg 20tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - rosuvastatiin+valsartaan - õhukese polümeerikattega tablett - 20mg+80mg 56tk; 20mg+80mg 60tk; 20mg+80mg 90tk; 20mg+80mg 14tk; 20mg+80mg 20tk; 20mg+80mg 30tk; 20mg+80mg 28tk

Eesti - eesti - Ravimiamet

krka d.d. novo mesto - fiproniil+metopreen - täpilahus - 50mg+60mg 0.5ml 0.5ml 10tk; 50mg+60mg 0.5ml 0.5ml 3tk; 50mg+60mg 0.5ml 0.5ml 1tk

Eesti - eesti - Ravimiamet

mepha-investigacao, desenvolvimento e fabricacao farmaceutica, lda - ibuprofeen - õhukese polümeerikattega tablett - 400mg 10tk; 400mg 100tk; 400mg 60tk; 400mg 20tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Euroopa Liit - eesti - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastilised ained - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.